PubMed Health⌕ Search

PubMed · 2652364

Experimental teeth clenching in man.

Abstract

The thesis develops an electromyographic (EMG) method to quantify maximum voluntary teeth clenching (MVC), studies the onset and endurance of jaw muscle fatigue and pain from MVC, and explores the prevention of the discomforts through pharmacological and physical means. MVC, or maximum voluntary static work efforts by the elevator muscles of the mandible, was quantified by continuous (integral) functions of variations in both time and recruitment/rate coding of motor units in the masseter muscle. Fatigue was felt in the masseter muscle after about 30 seconds of MVC; differential calculus suggested that the appearance and disappearance of fatigue was associated with primarily recruitment and decruitment of masseteric motor units, respectively. About 60 seconds of MVC elicited a mild pain in the masseter and temporalis muscles; about 120 seconds of MVC induced a moderate pain and complete exhaustion of the isometrically contracting muscles. Although pain releasing maximum static work efforts are stable variables they cannot predict the pain magnitude of brief and prolonged MVC, probably because of modulations (recruitment/decruitment/rate coding) of masseteric motor units. It is suggested that the modulations begin with the onset of fatigue, are practically complete with the onset of pain, and are absent or negligible with an experience of exhaustion. A single oral dose of 1000 mg of ibuprofen did not affect the onset, endurance, and magnitude of pain from MVC. By contrast, 30 minutes of cooling (ice) of the masseter muscle effectively prevented the onset of pain; it also increased the masseteric EMG, credibly because of modulations of myoelectrical signals and, possibly, increased MVC efforts in the absence of pain.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L V Christensen. 1989. Experimental teeth clenching in man.. https://pubmed.ncbi.nlm.nih.gov/2652364/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Current status of HIFU and cryotherapy in prostate cancer--a review.

OBJECTIVES: To evaluate the current status of high-intensity focused ultrasound (HIFU) and cryosurgery as the primary treatment option in patients with prostate cancer. METHOD: A MedLine search using specified search terms was done on February 28, 2005. This search rendered 150 papers related to HIFU and 566 papers related to cryosurgery. Very few of these papers presented original outcome data and are included in the present review. RESULTS: No controlled trial was available for analysis, and no survival data were presented. No validated biochemical, surrogate end point was available for any of the two therapies. HIFU showed progression-free survival (based on prostate-specific antigen+/-biopsy data) of 63-87% (projected 3- to 5-yr data), but median follow-up in the studies ranged from 12-24 mo. Negative postoperative biopsies was seen in 82-94% of patients. Complications have been reduced by the combination of transurethral resection of the prostate and HIFU. Cryosurgery showed a progression-free survival of 36-92% (projected 1-7 yr data), depending on risk groups and definition of failure. Negative biopsies were seen in 72-87%, but no biopsy data were available for the currently used third-generation cryotherapy machines. Complications seem to be lower with the third-generation machines. CONCLUSIONS: None of the evaluated therapies has enough data available to support their use as an alternative to established therapies (surgery, radiation) for localised prostate cancer. Until further data become available, the use of both treatments should be restricted to patients unfit for established therapies who still have the need for local therapy.

Cryotherapy↗

Thermal and flow measurements of continuous cryogenic spray cooling.

The performance of single sprays for high heat flux cooling using R-134a was studied. The heat flux and heat transfer coefficient at the surface of a sprayed jet based on measurements of steady-state temperature gradients on a thin copper plate during continuous spraying. Meanwhile, the spray droplets flow characteristics was also quantified through laser doppler velocimetry (LDV) measurements to obtain the local velocity distributions. The effects of mass flow rate and average droplet velocity, and spray exit-to-target distance on the surface heat flux including the corresponding critical heat flux (CHF) were explored through three different nozzle diameters of 0.2, 0.3, and 0.4 mm. Finally, the effective use of the fluid being delivered based on the cooling efficiency and cooling effectiveness was also examined. The relationship between CHF and nozzle performance in terms of cooling efficiency and cooling effectiveness was found. The heat transfer removal rate can reach up to 140 W/cm(2) for the present nozzle size of d (j)=0.2 and 0.3 mm, which may enhance the current cryogen spray cooling (CSC) technique that assists laser therapy of dermatoses.

Cryotherapy↗